Magellan Health Overview
Magellan Health (MGLN) has a P/E ratio of 593.69, above the Healthcare sector average of 25.93.
Get informed when a big investor buys or sells
+ Follow593.69
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Magellan Health (MGLN) currently reports a P/E ratio of 593.69. That is above the Healthcare sector average of 25.93. Use the charts on this page to explore Magellan Health's P/E ratio history and peer comparisons.
Magellan Health's P/E ratio of 593.69 is higher than the Healthcare sector average of 25.93. That is roughly 2189.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Magellan Health's market price to a fundamental measure such as earnings, sales, or book value. At 593.69, MGLN can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 593.69, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.93. From there, open related valuation or income-statement pages for Magellan Health, and consider following MGLN for alerts when major investors trade the stock.
Magellan Health is classified in the Healthcare sector. On P/E ratio, it currently shows 593.69 versus a sector average near 25.93. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MGLN with unrelated industries.
